Cargando…
Large1 gene transfer in older myd mice with severe muscular dystrophy restores muscle function and greatly improves survival
Muscular dystrophy is a progressive and ultimately lethal neuromuscular disease. Although gene editing and gene transfer hold great promise as therapies when administered before the onset of severe clinical symptoms, it is unclear whether these strategies can restore muscle function and improve surv...
Autores principales: | Yonekawa, Takahiro, Rauckhorst, Adam J., El-Hattab, Sara, Cuellar, Marco A., Venzke, David, Anderson, Mary E., Okuma, Hidehiko, Pewa, Alvin D., Taylor, Eric B., Campbell, Kevin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132445/ https://www.ncbi.nlm.nih.gov/pubmed/35613260 http://dx.doi.org/10.1126/sciadv.abn0379 |
Ejemplares similares
-
Inhibition of sphingolipid de novo synthesis counteracts muscular dystrophy
por: Laurila, Pirkka-Pekka, et al.
Publicado: (2022) -
ANT-dependent MPTP underlies necrotic myofiber death in muscular dystrophy
por: Bround, Michael J., et al.
Publicado: (2023) -
Optogenetic modeling of human neuromuscular circuits in Duchenne
muscular dystrophy with CRISPR and pharmacological corrections
por: Paredes-Redondo, Amaia, et al.
Publicado: (2021) -
DUX4 double whammy: The transcription factor that causes a rare muscular dystrophy also kills the precursors of the human nose
por: Inoue, Kaoru, et al.
Publicado: (2023) -
Preneoplastic somatic mutations including MYD88(L265P) in lymphoplasmacytic lymphoma
por: Rodriguez, Sara, et al.
Publicado: (2022)